We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitor... Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0629 | 9.29098966027 | 0.677 | 0.74 | 0.6532 | 141355 | 0.70186388 | CS |
4 | 0.0188 | 2.60712799889 | 0.7211 | 0.79 | 0.6 | 131939 | 0.7042061 | CS |
12 | 0.1099 | 17.4444444444 | 0.63 | 0.94 | 0.6 | 212002 | 0.75909528 | CS |
26 | 0.2299 | 45.0784313725 | 0.51 | 0.94 | 0.503 | 283649 | 0.68742318 | CS |
52 | -0.9601 | -56.4764705882 | 1.7 | 3.7 | 0.5 | 369492 | 0.98159797 | CS |
156 | -4.9501 | -86.9964850615 | 5.69 | 16.41 | 0.5 | 277817 | 3.09968817 | CS |
260 | -15.0301 | -95.3081800888 | 15.77 | 17.99 | 0.5 | 242892 | 3.27454936 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions